18 start-ups have been selected from the record number of 300 entries to present their innovations. We are proud of Bioceltix, which have won in the category of medicine, health, medical technologies, pharmacy, biotechnology. The jury awarded Bioceltix for ambitious clinical research plan, developed business model and the ability to scale solutions. The team’s competences were also appreciated. Bioceltix is one of the global pioneers implementing animal-safe and business-scaled technology of the therapeutic use of animal, allogenic (one donor – many recipients) stem cells.
We warmly congratulate the team Bioceltix We keep our fingers crossed for effective commercialization!